Delayed mTOR Inhibition with Low Dose of Everolimus Reduces TGFβ Expression, Attenuates Proteinuria and Renal Damage in the Renal Mass Reduction Model

mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure rats

(2009) Shunsaku Nakagawa et al.   BIOCHEMICAL PHARMACOLOGY

The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease

(2009) W. Lieberthal et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice

(2009) M. Teresa Grande et al.   KIDNEY INTERNATIONAL

Fibroblast activation and myofibroblast generation in obstructive nephropathy

(2009) María T. Grande et al.   Nature Reviews Nephrology

Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)

(2009) I. Zafar et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mammalian Target of Rapamycin Inhibition Prevents Glomerular Hypertrophy in a Model of Renal Mass Reduction

(2009) Jordi Rovira et al.   TRANSPLANTATION

Distinct Roles for Mammalian Target of Rapamycin Complexes in the Fibroblast Response to Transforming Growth Factor- 

(2008) R. A. Rahimi et al.   CANCER RESEARCH

The mTOR Inhibitor Everolimus Attenuates the Time Course of Chronic Anti-Thy1 Nephritis in the Rat

(2008) Sandra Wittmann et al.   NEPHRON EXPERIMENTAL NEPHROLOGY

mToR inhibitors-induced proteinuria: mechanisms, significance, and management

(2008) Emmanuel Letavernier et al.   Transplantation Reviews